高级检索
当前位置: 首页 > 详情页

A MicroRNA Checkpoint for Ca2+ Signaling and Overload in Acute Pancreatitis.

文献详情

资源类型:
Pubmed体系:
机构: [1]Division of Endocrinology and Metabolism, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041 Sichuan, China [2]Department of Integrated Traditional Chinese and WesternMedicine, Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, 610041Sichuan, China [3]Institutes for Systems Genetics & Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West ChinaHospital, Sichuan University, Chengdu, 610041 Sichuan, China [4]Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, JagiellonianUniversity, 30-387 Krakow, Poland [5]Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Krakow, Poland [6]Liverpool Pancreatitis Research Group,Liverpool University Hospitals NHS Foundation Trust and Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, LiverpoolL69 3GE, UK [7]Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L693GE, UK [8]Center for Diabetes and Metabolism Research, Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041Sichuan, China [9]The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, 17176 Stockholm, Sweden [10]Department of DiabetesComplications and Metabolism, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA [11]West China Biobanks, Department of Clinical ResearchManagement, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China
出处:
ISSN:

摘要:
Acute pancreatitis (AP) is a common digestive disease without specific treatment and its pathogenesis features multiple deleterious amplification loops dependent on translation, triggered by cytosolic Ca2+ ([Ca2+]i) overload, however the underlying mechanisms in Ca2+ overload of AP remains incompletely understood. Here we show that microRNA-26a (miR-26a) inhibits pancreatic acinar cell (PAC) store-operated Ca2+ entry (SOCE) channel expression, Ca2+ overload, and AP. We find that major SOCE channels are post-transcriptionally induced in PACs during AP, whereas miR-26a expression is reduced in experimental and human AP and correlated with AP severity. Mechanistically, miR-26a simultaneously targets Trpc3 and Trpc6 SOCE channels and attenuates physiological oscillations and pathological elevations of [Ca2+]i in PACs. MiR-26a deficiency increases SOCE channel expression and [Ca2+]i overload, and significantly exacerbates AP. Conversely, global or PAC-specific overexpression of miR-26a in mice ameliorates pancreatic edema, neutrophil infiltration, acinar necrosis, and systemic inflammation, accompanied with remarkable improvements on pathological determinants related with [Ca2+]i overload. Moreover, pancreatic or systemic administration of an miR-26a mimic to mice significantly alleviates experimental AP. These findings reveal a previously unknown mechanism underlying AP pathogenesis, establish a critical role for miR-26a in Ca2+ signaling in the exocrine pancreas and identify a potential target for the treatment of AP.Copyright © 2022. Published by Elsevier Inc.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 遗传学 1 区 生物工程与应用微生物 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生物工程与应用微生物 1 区 遗传学 1 区 医学:研究与实验
第一作者:
第一作者机构: [1]Division of Endocrinology and Metabolism, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041 Sichuan, China
共同第一作者:
通讯作者:
通讯机构: [1]Division of Endocrinology and Metabolism, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041 Sichuan, China [2]Department of Integrated Traditional Chinese and WesternMedicine, Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, 610041Sichuan, China [3]Institutes for Systems Genetics & Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West ChinaHospital, Sichuan University, Chengdu, 610041 Sichuan, China [6]Liverpool Pancreatitis Research Group,Liverpool University Hospitals NHS Foundation Trust and Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, LiverpoolL69 3GE, UK [11]West China Biobanks, Department of Clinical ResearchManagement, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China [*1]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 17 Renmin South Road, Chengdu 610041, China. [*2]Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, No 88 Keyuan South Road, Chengdu 610041, China. [*3]State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 17 Renmin South Road, Chengdu 610041, China. [*4]Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool and Liverpool University Hospitals NHS Foundation Trust, Ashton Street, Liverpool L69 3GE, United Kingdom
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号